ZORBAX StableBond 300 C8, 4.6 x 100 mm, 3.5 µm. A reversed-phase C8 HPLC column with fully porous ZORBAX particles. StableBond technology ensures stability at low pH.
Specifications:
Brand: ZORBAX 300SB-C8
Hardware: SS
Inner Diameter (ID): 4.6 mm
LC Platform: Stainless Steel
Length: 100 mm
Maximum Temperature: 80 °C
Part Number Application Domain: Biopharma
Part Number Application: Monoclonal Antibodies (mABs)PeptidesProteins
Particle Size: 3.5 µm
Particle Type: Fully Porous
Phase: 300SB-C8
Pore Size: 300 Å
Pressure Rating: 400 bar
Separation Mode: Reversed Phase
Shipping Solvent: Acetonitrile/Water
Technique: LCLC & LC/MS
UNSPSC Code: 41115709
pH Range: 1-8
**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
Designed for robust and reproducible reversed-phase chromatography, this column is engineered with a proprietary StableBond end-capping process that ensures high stability under low pH conditions, making it ideal for peptide and protein separations. The C8 bonded phase and 300 angstrom pore size facilitate reliable retention and resolution for moderately hydrophobic biomolecules, while the 3.5 micrometer particle size delivers a balance of efficiency and speed without excessive backpressure. With dimensions of 4.6 by 100 millimeters, this column supports standard analytical HPLC methods and is widely used in research settings for the analysis of biotherapeutics, peptide mapping, and protein characterization. Suitable for use with Agilent 1100, 1200, and 1290 Infinity LC systems as well as a variety of other compatible HPLC instruments, it integrates seamlessly into existing workflows. Researchers benefit from the column’s consistent performance in high-throughput laboratories and its compatibility with multiple mobile phases. Agilent offers a range of ZORBAX StableBond columns in various chemistries and dimensions to support diverse analytical needs, enabling flexible method development and transfer across laboratories.